Humphrey, Kathryn
Roche (United Kingdom)
3 papers on CoChat
Most cited papers
- Verified
Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
Seymour, J. F., Kipps, T. J., Eichhorst, B., Hillmen, P., D’Rozario, J., Assouline, S., Owen, C., Gerecitano, J., Robak, T., De la Serna, J., et al. (2018) · New England Journal of Medicine
Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment
Cited by 940
- Verified
Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables
Roberts, A. W., Ma, S., Kipps, T. J., Coutre, S. E., Davids, M. S., Eichhorst, B., Hallek, M., Byrd, J. C., Humphrey, K., Zhou, L., et al. (2019) · Blood
Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment
Cited by 178
- Verified
Population Pharmacokinetics and Exposure-Response Analyses for Glofitamab in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R NHL): Confirmation of Efficacy and CRS Mitigation in Patients with Step-up Dosing
Djebli, N., Morcos, P. N., Jaminion, F., Guerini, E., Kratochwil, N. A., Justies, N., Schick, E., Kwan, A., Humphrey, K., Lundberg, L., et al. (2020) · Blood
Lymphoma Diagnosis and TreatmentMonoclonal and Polyclonal Antibodies Research
Cited by 16
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free